• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左旋多巴诱导的运动障碍、运动波动和与健康相关的生活质量:COPARK 调查。

L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.

机构信息

INSERM, Services de Pharmacologie Clinique et Neurosciences, Centre d'Investigation Clinique CIC 1436, NS-Park/FCRIN Network, NeuroToul COEN Center, Université de Toulouse UPS, CHU de Toulouse, Toulouse, France.

Institute of Cardiology Research, University of Buenos Aires, National Research Council (CONICET-ININCA), Buenos Aires, Argentina.

出版信息

Eur J Neurol. 2017 Dec;24(12):1532-1538. doi: 10.1111/ene.13466. Epub 2017 Oct 9.

DOI:10.1111/ene.13466
PMID:28940893
Abstract

BACKGROUND AND PURPOSE

Studies assessing the correlations between L-DOPA-induced dyskinesias (LIDs) and motor fluctuations with health-related quality of life (HRQoL) in Parkinson's disease (PD) have yielded conflicting results. This study aimed to assess the relationship between LIDs and motor fluctuations with HRQoL in patients with PD, and to assess the relative contribution of their severity and duration in a large sample of patients with PD.

METHODS

A total of 683 patients with PD from the COPARK survey were evaluated. HRQoL was assessed using the 39-Item Parkinson's Disease Questionnaire (PDQ-39) (primary outcome) and 36-Item Short Form Survey (SF-36). The daily duration and severity of LIDs were obtained from Unified Parkinson's Disease Rating Scale (UPDRS) IV items 32 and 33, respectively. The daily duration of motor fluctuations was obtained from UPDRS IV item 36 and severity was estimated as the difference between the UPDRS 2 (Activities of Daily Living) score in 'OFF' versus 'ON' condition.

RESULTS

A total of 235 patients with PD (35%) experienced motor fluctuations and 182 (27%) experienced LIDs. The PDQ-39 total and SF-36 physical scores were significantly worse in patients with LIDs, after adjusting for the presence of motor fluctuations. The PDQ-39 total score and SF-36 physical and mental score were significantly worse in patients with motor fluctuations, after adjusting for the presence of LIDs. The severity of LIDs and the duration of motor fluctuations significantly and independently affected PDQ-39 scores. The SF-36 physical score was affected only by the severity of motor fluctuations, whereas the mental score was not affected by any of the aforementioned variables.

CONCLUSION

Our findings suggest that LIDs (mainly their severity) and motor fluctuations (mainly their duration) correlate independently with HRQoL in patients with PD.

摘要

背景与目的

评估左旋多巴诱导的运动障碍(LIDs)与帕金森病(PD)患者的健康相关生活质量(HRQoL)之间的相关性的研究结果相互矛盾。本研究旨在评估 PD 患者中 LIDs 和运动波动与 HRQoL 的关系,并在大量 PD 患者样本中评估其严重程度和持续时间的相对贡献。

方法

评估了 COPARK 调查中的 683 名 PD 患者。使用帕金森病问卷 39 项(PDQ-39)(主要结局)和 36 项简短健康调查问卷(SF-36)评估 HRQoL。LIDs 的每日持续时间和严重程度分别从统一帕金森病评定量表(UPDRS)IV 项 32 和 33 中获得。运动波动的每日持续时间从 UPDRS IV 项 36 中获得,严重程度估计为“OFF”与“ON”状态下 UPDRS 2(日常生活活动)评分之间的差值。

结果

共有 235 名 PD 患者(35%)出现运动波动,182 名(27%)出现 LIDs。调整运动波动的存在后,LIDs 患者的 PDQ-39 总分和 SF-36 生理评分明显更差。调整 LIDs 的存在后,运动波动患者的 PDQ-39 总分和 SF-36 生理和心理评分明显更差。LIDs 的严重程度和运动波动的持续时间显著且独立地影响 PDQ-39 评分。SF-36 生理评分仅受运动波动严重程度的影响,而心理评分不受上述任何变量的影响。

结论

我们的发现表明,LIDs(主要是其严重程度)和运动波动(主要是其持续时间)与 PD 患者的 HRQoL 独立相关。

相似文献

1
L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.左旋多巴诱导的运动障碍、运动波动和与健康相关的生活质量:COPARK 调查。
Eur J Neurol. 2017 Dec;24(12):1532-1538. doi: 10.1111/ene.13466. Epub 2017 Oct 9.
2
Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.左旋多巴对晚期帕金森病的疗效和运动功能的影响。
J Parkinsons Dis. 2018;8(1):59-70. doi: 10.3233/JPD-171181.
3
Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.中国特发性帕金森病患者运动并发症发生的危险因素
J Clin Neurosci. 2009 Aug;16(8):1034-7. doi: 10.1016/j.jocn.2008.10.015. Epub 2009 May 9.
4
Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.晚期帕金森病患者左旋多巴的药代动力学-药效学建模
Clin Neuropharmacol. 2010 May;33(3):135-41. doi: 10.1097/WNF.0b013e3181d47849.
5
AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.AFQ056 在伴有左旋多巴诱导运动障碍的帕金森病患者中的 13 周、随机、剂量发现研究。
Mov Disord. 2013 Nov;28(13):1838-46. doi: 10.1002/mds.25561. Epub 2013 Jul 12.
6
Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.左旋多巴与恩他卡朋联合使用对出现剂末现象波动的患者生活质量和日常生活活动的疗效。
Acta Neurol Scand. 2005 Jan;111(1):21-8. doi: 10.1111/j.1600-0404.2004.00363.x.
7
Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.早期帕金森病的生活质量:异动症和运动波动的影响。
Mov Disord. 2004 Jan;19(1):22-8. doi: 10.1002/mds.10642.
8
Impact of the motor complications of Parkinson's disease on the quality of life.帕金森病运动并发症对生活质量的影响。
Mov Disord. 2005 Feb;20(2):224-30. doi: 10.1002/mds.20279.
9
[Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].[帕金森病患者左旋多巴诱发异动症的社会和经济成本]
Rev Neurol (Paris). 2001 May;157(5):507-14.
10
Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.丘脑底核深部脑刺激调节帕金森病患者术后儿茶酚胺水平,且与临床结局显著相关。
PLoS One. 2015 Sep 22;10(9):e0138462. doi: 10.1371/journal.pone.0138462. eCollection 2015.

引用本文的文献

1
Neurophysiological Treatment Effects of Mesdopetam, Pimavanserin and Amantadine in a Rodent Model of Levodopa-Induced Dyskinesia.美司多巴、匹莫范色林和金刚烷胺在左旋多巴诱导的异动症啮齿动物模型中的神经生理学治疗效果
Eur J Neurosci. 2025 Mar;61(5):e70032. doi: 10.1111/ejn.70032.
2
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study.左旋多巴诱导的运动障碍在帕金森病中很常见,且影响生活质量:一项为期 5 年的随访研究。
Mov Disord Clin Pract. 2024 Jul;11(7):830-849. doi: 10.1002/mdc3.14056. Epub 2024 May 15.
3
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease.
基于模型的皮下与舌下注射阿扑吗啡治疗帕金森病运动波动的比较
J Pharmacokinet Pharmacodyn. 2024 Aug;51(4):385-393. doi: 10.1007/s10928-024-09914-x. Epub 2024 Apr 5.
4
The Dynamics of Dopamine D Receptor-Expressing Striatal Neurons and the Downstream Circuit Underlying L-Dopa-Induced Dyskinesia in Rats.多巴胺 D 受体表达纹状体神经元的动力学及其在大鼠左旋多巴诱导运动障碍中的下游回路。
Neurosci Bull. 2023 Sep;39(9):1411-1425. doi: 10.1007/s12264-023-01054-5. Epub 2023 Apr 6.
5
Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson's Disease: A Monocentric Retrospective Study.发病年龄对帕金森病早期运动和非运动症状进展的影响:一项单中心回顾性研究
Brain Sci. 2023 Jan 17;13(2):157. doi: 10.3390/brainsci13020157.
6
Relationship Between Gut Bacteria and Levodopa Metabolism.肠道细菌与左旋多巴代谢的关系。
Curr Neuropharmacol. 2023;21(7):1536-1547. doi: 10.2174/1570159X21666221019115716.
7
Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis.多巴胺代谢和信号通路的多态性与帕金森病运动性左旋多巴诱导并发症(MLIC)的易感性有关:系统评价和荟萃分析。
Neurol Sci. 2022 Jun;43(6):3649-3670. doi: 10.1007/s10072-021-05829-4. Epub 2022 Jan 25.
8
Effects of rasagiline on Parkinson's Disease Questionnaire (PDQ-39) emotional well-being domain in patients with Parkinson's disease: A post-hoc analysis of clinical trials in Japan.雷沙吉兰对帕金森病患者帕金森病问卷(PDQ-39)情感幸福领域的影响:日本临床试验的事后分析
PLoS One. 2022 Jan 25;17(1):e0262796. doi: 10.1371/journal.pone.0262796. eCollection 2022.
9
Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson's Disease: Focus on Neuroinflammation.左旋多巴诱导的帕金森病异动症患者的血浆和脑脊液代谢特征:聚焦神经炎症。
Mol Neurobiol. 2022 Feb;59(2):1140-1150. doi: 10.1007/s12035-021-02625-1. Epub 2021 Dec 2.
10
Dyskinesia estimation during activities of daily living using wearable motion sensors and deep recurrent networks.使用可穿戴运动传感器和深度递归网络进行日常活动中的运动障碍估计。
Sci Rep. 2021 Apr 12;11(1):7865. doi: 10.1038/s41598-021-86705-1.